CMMC 2.0 Scoping Guidance Limits the Scope of Cybersecurity Assessments
Client Alert | 1 min read | 12.23.21
The Department of Defense (DoD) recently released the initial guidance documents for Version 2.0 of its Cybersecurity Maturity Model Certification (CMMC) program, including its much-anticipated Scoping Guidance. While the guidance documents generally adhere to the current requirements for the protection of Federal Contract Information (FCI) and Controlled Unclassified Information (CUI), the Scoping Guidance includes notable developments. Chief among them is the introduction of two asset categories — “Specialized Assets” and “Contractor Risk Managed Assets” — that could potentially limit the scope of a contractor’s CMMC assessment, as well as the number and types of assets to be assessed against the applicable CMMC practices.
- Specialized Assets include government property; internet of things (IoT) and industrial internet of things (IIoT) devices; operational technology; systems configured based entirely on government requirements and used to support a contract; and test equipment.
- Contractor Risk Managed Assets include computing resources that are capable of handling CUI but are prevented from doing so by the contractor’s security policies, procedures, and practices.
Contractors expecting to be subject to CMMC should carefully review the Scoping Guidance, as well as the other guidance documents, to determine whether and how they may wish to limit the scope of CMMC’s applicability.
Contacts

Partner and Crowell Global Advisors Senior Director
- Washington, D.C.
- D | +1.202.624.2698
- Washington, D.C. (CGA)
- D | +1 202.624.2500
Insights
Client Alert | 6 min read | 04.29.26
CMS Seeks to Expand Interoperability Requirements to Drug Pre-Authorization (FAQ)
On April 10, 2026, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (2026 CMS Interoperability Standards and Prior Authorization for Drugs, or CMS-0062-P) outlining the agency’s plans to impose new interoperability requirements on payors participating in certain Medicare and Medicaid programs. As described by the agency in a recent press release, the proposed rule “builds on” prior rulemaking by clarifying and enhancing interoperability requirements for payors’ prior authorization processes, specifically those associated with coverage requests for pharmaceutical therapies.
Client Alert | 8 min read | 04.27.26
Client Alert | 5 min read | 04.27.26
Drift Protocol Exploit: Why “Social Trust” Is the Newest Cybersecurity Gap
Client Alert | 4 min read | 04.27.26
Gaming Addiction Litigation: Turner v. Epic Games & Roblox and What It Means for the Industry

